A comprehensive review on seroepidemiology and molecular epidemiology of hepatitis E Virus in Iran.

Q3 Medicine
Amir Hossein Aghapour, Seyed Masoud Hosseini, Shahrzad Shoraka, Amir Ghaemi, Afsaneh Sharifian, Seyed Reza Mohebbi
{"title":"A comprehensive review on seroepidemiology and molecular epidemiology of hepatitis E Virus in Iran.","authors":"Amir Hossein Aghapour, Seyed Masoud Hosseini, Shahrzad Shoraka, Amir Ghaemi, Afsaneh Sharifian, Seyed Reza Mohebbi","doi":"10.22037/ghfbb.v18i4.3102","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis E virus (HEV) is a global threat to human health. The virus can cause acute liver disease in infected people, and although it is self-limiting in most people infected, it can cause serious liver problems and even death in some individuals, including pregnant women. HEV has eight genotypes, but usually four of its genotypes have been reported to cause infection in humans. Hepatitis E is expected to cause 20 million infections worldwide in a year, with 3.3 million symptomatic cases and about 44000 deaths. It's considered endemic in many developing countries, and poses a threat to global health. Mortality among pregnant women and newborns also highlights the importance of the control of the virus and the need for comprehensive techniques to monitor and reduce its spread. One way of transmitting HEV is through contaminated water and food, especially in the event of flooding. In addition, products of raw or undercooked meat from animals such as pigs and camels are likely to be a problem in developed countries. With close monitoring, the global prevalence of HEV can be reduced. It can also be significantly controlled with the availability of effective vaccines and improved hygiene standards. This review focuses on the molecular virology of HEV, pathogenesis, epidemiology, diagnostic methods, transmission routes and treatment options.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"18 4","pages":"390-412"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12920706/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterology and Hepatology From Bed to Bench","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/ghfbb.v18i4.3102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatitis E virus (HEV) is a global threat to human health. The virus can cause acute liver disease in infected people, and although it is self-limiting in most people infected, it can cause serious liver problems and even death in some individuals, including pregnant women. HEV has eight genotypes, but usually four of its genotypes have been reported to cause infection in humans. Hepatitis E is expected to cause 20 million infections worldwide in a year, with 3.3 million symptomatic cases and about 44000 deaths. It's considered endemic in many developing countries, and poses a threat to global health. Mortality among pregnant women and newborns also highlights the importance of the control of the virus and the need for comprehensive techniques to monitor and reduce its spread. One way of transmitting HEV is through contaminated water and food, especially in the event of flooding. In addition, products of raw or undercooked meat from animals such as pigs and camels are likely to be a problem in developed countries. With close monitoring, the global prevalence of HEV can be reduced. It can also be significantly controlled with the availability of effective vaccines and improved hygiene standards. This review focuses on the molecular virology of HEV, pathogenesis, epidemiology, diagnostic methods, transmission routes and treatment options.

伊朗戊型肝炎病毒血清流行病学和分子流行病学综述
戊型肝炎病毒(HEV)是对人类健康的全球性威胁。该病毒可在感染者中引起急性肝脏疾病,尽管在大多数感染者中是自限性的,但它可导致严重的肝脏问题,甚至导致一些人死亡,包括孕妇。HEV有八种基因型,但据报道,通常有四种基因型引起人类感染。戊型肝炎预计每年在全世界造成2000万例感染,其中330万例有症状,约4.4万人死亡。它被认为是许多发展中国家的地方病,并对全球健康构成威胁。孕妇和新生儿的死亡率也突出了控制该病毒的重要性以及监测和减少其传播的综合技术的必要性。传播戊肝病毒的一种途径是通过受污染的水和食物,特别是在发生洪水时。此外,猪和骆驼等动物的生肉或未煮熟的肉制品在发达国家可能会成为一个问题。通过密切监测,可以降低戊肝病毒的全球流行率。通过提供有效的疫苗和改善卫生标准,也可以大大控制该病。本文就HEV的分子病毒学、发病机制、流行病学、诊断方法、传播途径和治疗方案进行综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
29
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书